News | Magnetic Resonance Imaging (MRI) | December 05, 2021

The new European Union Medical Devices Regulation (MDR), Regulation (EU) 2017/745, came into force on May 26, 2021

Esaote, a leading Italian company in the biomedical sector, in ultrasound, dedicated magnetic resonance imaging and information technology for healthcare, is pleased to announce that the new Magnifico Open total-body magnetic resonance system has obtained EC MDR certification.

December 5, 2021 — Esaote, a leading Italian company in the biomedical sector, in ultrasound, dedicated magnetic resonance imaging and information technology for healthcare, is pleased to announce that the new Magnifico Open total-body magnetic resonance system has obtained EC MDR certification.

The new certification attests to the Magnifico Open system’s compliance with the requirements of the new European Union Medical Devices Regulation (MDR), Regulation (EU) 2017/745, which entered into force on May 26, 2021.

The new regulation, replacing Directive 93/42/EEC on medical devices (MDD) and others, was implemented by the European Parliament to improve the EU approval system for medical devices, by imposing strict requirements on both manufacturers and Notified Bodies involved in the conformity assessment of those devices.

The MDR certification for the Esaote Magnifico Open was issued by the internationally recognized TÜV SÜD certification body, one of the first Notified Bodies in the world to receive authorization to provide certification according to the new regulation.

The evaluation criteria in the new Regulation include more precise and rigorous requirements in terms of the content and scope of the technical documentation required for medical devices and for manufacturers’ Quality Management Systems; for clinical assessments and investigations, especially the type, purpose and quality of clinical data; for product evaluation and after-sales surveillance, which must be guaranteed at all times.

“We’re very proud that our new Magnifico Open total-body magnetic resonance system meets the strict regulatory requirements of the MDR,” noted Massimo Polignano, chief quality officer at Esaote. “It is a highly complex process, one we engaged in immediately at the same time as in the process to develop the system itself. It is a new milestone, acknowledging Esaote’s constant commitment to bring safe and reliable diagnostic systems to the market, with the utmost respect for the health and protection of users and patients, on whom our everyday work is always focused.”

Magnifico Open, which adds to the range of Esaote products unveiled in 2021, is an open magnetic resonance system with the latest technology. The wide choice of receiver coils and state-of-the-art MRI technology offer the user excellent image quality, while the permanent magnet makes it easy to use and lowers operating costs. The open magnet and the easy-to-access patient table also facilitate, speed up and make patient positioning more comfortable, ideal for both the claustrophobic and for children.

For more information: www.esaote.com

Find more RSNA news and videos

Related Content

News | Digital Radiography (DR)

January 25, 2022 — Carestream Health was awarded 45 new patents in 2021 for global advances in artificial intelligence ...

Time January 26, 2022
arrow
News | Radiology Education

January 25, 2022 — Technical Prospects, a leader in the medical imaging industry, has announced the launch of its BioMed ...

Time January 25, 2022
arrow
News | Lung Imaging

January 25, 2022 — A new study based on data from a national cancer registry in Taiwan found evidence that lung cancer ...

Time January 25, 2022
arrow
Sponsored Content | Videos | Magnetic Resonance Imaging (MRI)

With the recent launch of the Magnifico Open, Italian company Esaote has entered the open MRI whole body space. ITN had ...

Time January 24, 2022
arrow
News | Ultrasound Imaging

January 21, 2022 — According to an article in ARRS’ American Journal of Roentgenology (AJR), preoperative shear wave ...

Time January 21, 2022
arrow
Sponsored Content | Case Study | Computed Tomography (CT)

Approximately thirteen men out of every 100 will get prostate cancer during their lifetime, and about two to three men ...

Time January 21, 2022
arrow
Feature | Radiology Business | By Jef Williams

The Great Resignation has impacted every industry, including ours. While this movement will be studied for years to come ...

Time January 20, 2022
arrow
Feature | Vendor Neutral Archive (VNA)

Vendor neutral archives (VNAs) have become a staple within the healthcare IT system. At the Radiological Society of ...

Time January 20, 2022
arrow
Feature | Contrast Media Injectors | By Melinda Taschetta-Millane

Contrast media injectors are used to inject contrast agents to enhance the blood and perfusion in tissues. There have ...

Time January 19, 2022
arrow
Feature | Coronavirus (COVID-19) | By Avielle Siegel, Paul J. Chang, David M. Paushter, et al.

A 26-year-old man with history of diabetes and hypertension presented with 7 days of fever, chills, nausea, intractable ...

Time January 19, 2022
arrow
Subscribe Now